Calvert Investment Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Calvert Investment Management's ABBV Position: Q1 2017 in Review
Calvert Investment Management sold out of AbbVie (ABBV) in Q1 2017, closing a stake of 103,648 shares — an estimated $6.49M sold.
Calvert Investment Management first reported a position in ABBV in Q3 2013 and held it in 14 quarters. The position peaked at $6.57M in Q3 2016. 1,727 funds tracked by Wall St. Rank hold ABBV as of Q1 2017.
- Calvert Investment Management reported no remaining AbbVie position as of Q1 2017 after selling out during the quarter.
- Calvert Investment Management sold 103,648 AbbVie shares in Q1 2017, an estimated $6.49M.
- Calvert Investment Management first reported a position in AbbVie in Q3 2013 and held it in 14 quarters.
- Calvert Investment Management's AbbVie position peaked at $6.57M in Q3 2016.
- 1,727 funds tracked by Wall St. Rank held AbbVie as of Q1 2017.
Based on Calvert Investment Management's 13F filing for Q1 2017.